Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;24(6):444-51.
doi: 10.2188/jea.je20140028. Epub 2014 Jul 5.

The dose-response relationship between body mass index and the risk of incident stage ≥3 chronic kidney disease in a general japanese population: the Ibaraki prefectural health study (IPHS)

Affiliations

The dose-response relationship between body mass index and the risk of incident stage ≥3 chronic kidney disease in a general japanese population: the Ibaraki prefectural health study (IPHS)

Takehiko Tsujimoto et al. J Epidemiol. 2014.

Abstract

Purpose: To examine the relationship between body mass index (BMI) and the risk of stage ≥3 chronic kidney disease (CKD) in a general Japanese population.

Methods: A total of 105 611 participants aged 40-79 years who completed health checkups in Ibaraki Prefecture, Japan, and were free of CKD in 1993 were followed-up through 2006. Stage ≥3 CKD was defined by an estimated glomerular filtration rate <60 mL/min/1.73 m(2) reported during at least 2 successive annual surveys or as treatment for kidney disease. Hazard ratios (HRs) for the development of stage ≥3 CKD relative to the BMI categories were calculated using the Cox proportional hazards regression model, which was adjusted for possible confounders and mediators.

Results: During a mean follow-up of 5 years, 19 384 participants (18.4%) developed stage ≥3 CKD. Compared to a BMI of 21.0-22.9 kg/m(2), elevated multivariable-adjusted HRs were observed among men with a BMI ≥23.0 kg/m(2) and women with a BMI ≥27.0 kg/m(2). Significant dose-response relationships between BMI and the incidence of stage ≥3 CKD were observed in both sexes (P for trend <0.001).

Conclusions: Obesity was associated with the risk of developing stage ≥3 CKD among men and women.

【目的】: 日本人におけるbody mass index(BMI)とステージ3以上の慢性腎臓病発症リスクとの関連を検討すること。

【方法】: 対象者は、茨城県内における1993年の基本健康診査の受診者で慢性腎臓病の既往歴のない40~74歳の男女105611人であった。対象者の慢性腎臓病発症を2006年まで追跡した。ステージ3以上の慢性腎臓病発症の定義は推定糸球体濾過量が2回以上の健診で60 ml/min/1.73 m2未満となった時点、もしくは腎臓病治療開始時点とした。 BMI区分(18.5未満、18.5~20.9、21.0~22.9、23.0~24.9、25.0~26.9、27.0~29.9、30.0以上)の慢性腎臓病発症に対する多変量調整ハザード比はCoxの比例ハザードモデルを用いて算出し、可能性のある交絡要因で調整した。

【結果】: 平均5年の追跡期間中に19384人(男性6283人、女性14015人)のステージ3以上の慢性腎臓病発症が確認された。ステージ3以上の慢性腎臓病発症に対する多変量調整ハザード比は、BMIが21.0~22.9を基準とした場合、男性でBMIが23.0以上、女性でBMIが27.0以上で有意に高値を示した。また、男女ともに、BMIとステージ3以上の慢性腎臓病発症率との間に量・反応関係が認められた。

【まとめ】: 肥満は、男女ともにステージ3以上の慢性腎臓病の発症リスクと関連する。

PubMed Disclaimer

Figures

Figure.
Figure.. The multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the development of stage ≥3 chronic kidney disease (CKD) in men and women.

References

    1. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. . Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30. 10.1007/s10157-009-0199-x - DOI - PubMed
    1. Weiner DE, Tabatabai S, Tighiouart H, Elsayed E, Bansal N, Griffith J, et al. . Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis. 2006;48:392–401. 10.1053/j.ajkd.2006.05.021 - DOI - PubMed
    1. Weinstein AR, Sesso HD, Lee IM, Cook NR, Manson JE, Buring JE, et al. . Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA. 2004;292:1188–94. 10.1001/jama.292.10.1188 - DOI - PubMed
    1. Sasai H, Sairenchi T, Iso H, Irie F, Otaka E, Tanaka K, et al. . Relationship between obesity and incident diabetes in middle-aged and older Japanese adults: the Ibaraki Prefectural Health Study. Mayo Clin Proc. 2010;85:36–40. 10.4065/mcp.2009.0230 - DOI - PMC - PubMed
    1. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358:1682–6. 10.1016/S0140-6736(01)06710-1 - DOI - PubMed

Publication types